المؤلفون: Mastellos, Dimitrios C, Yancopoulou, Despina, Kokkinos, Petros, Huber Lang, Markus, Hajishengallis, George, Biglarnia, Ali R., Lupu, Florea, Nilsson, Bo, Ricklin, Daniel, Lambris, John D., RISITANO, ANTONIO MARIA

المساهمون: Mastellos, Dimitrios C, Yancopoulou, Despina, Kokkinos, Petro, Huber Lang, Marku, Hajishengallis, George, Biglarnia, Ali R., Lupu, Florea, Nilsson, Bo, Risitano, ANTONIO MARIA, Ricklin, Daniel, Lambris, John D.

مصطلحات موضوعية: Clinical translation, Complement-based drug design, Compstatin, Cp40, Nonhuman primate model, Peptidic C3 inhibitor, Animal, Complement C3, Drug Design, Drug Discovery, Human, Peptide, Complement Inactivating Agent, Peptides, Cyclic, Medicine (all), Clinical Biochemistry, Biochemistry

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000352008100007; volume:45; issue:4; firstpage:423; lastpage:440; numberofpages:18; journal:EUROPEAN JOURNAL OF CLINICAL INVESTIGATION; http://hdl.handle.net/11588/657165Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84925962102; http://www3.interscience.wiley.com/journal/118482631/homeTest

الإتاحة: https://doi.org/10.1111/eci.12419Test
http://hdl.handle.net/11588/657165Test
http://www3.interscience.wiley.com/journal/118482631/homeTest

المؤلفون: Petros Kokkinos, George Hajishengallis, Florea Lupu, Markus Huber-Lang, Dimitrios C. Mastellos, Bo Nilsson, Antonio M. Risitano, Daniel Ricklin, John D. Lambris, Despina Yancopoulou, Ali Reza Biglarnia

المساهمون: Mastellos, Dimitrios C, Yancopoulou, Despina, Kokkinos, Petro, Huber Lang, Marku, Hajishengallis, George, Biglarnia, Ali R., Lupu, Florea, Nilsson, Bo, Risitano, ANTONIO MARIA, Ricklin, Daniel, Lambris, John D.

المصدر: European journal of clinical investigation. 45(4)

مصطلحات موضوعية: Drug, In silico, media_common.quotation_subject, Clinical Biochemistry, Computational biology, Bioinformatics, Biochemistry, Peptides, Cyclic, Article, Complement inhibitor, Drug Discovery, Medicine, Animals, Humans, Opsonin, media_common, Cp40, Innate immune system, Drug discovery, business.industry, Animal, Clinical translation, Medicine (all), Complement-based drug design, General Medicine, Complement C3, Complement system, Cell killing, Complement Inactivating Agent, Complement Inactivating Agents, Nonhuman primate model, Peptidic C3 inhibitor, Drug Design, Peptide, Compstatin, business, Peptides, Human

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d46d97a4f0069b849ecc3021c07e416Test
https://pubmed.ncbi.nlm.nih.gov/25678219Test